This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, M.
Right arrow Articles by Yumoto, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, M.
Right arrow Articles by Yumoto, N.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 1998, p. 2745-2746, Vol. 42, No. 10
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Enhancement of Antimicrobial Activity of Neuropeptide Y by N-Terminal Truncation

Mayumi Shimizu, Yasushi Shigeri, Yoshiro Tatsu, Susumu Yoshikawa, and Noboru Yumoto*

Osaka National Research Institute, AIST, Ikeda, Osaka 563-8577, Japan

Received 13 April 1998/Returned for modification 13 May 1998/Accepted 10 July 1998

    ABSTRACT
Top
Abstract
Text
References

The activity of neuropeptide Y (NPY) against Candida albicans, which was revealed to be fungicidal, was enhanced significantly by the truncation of amino acid residues at the N terminus. The most active peptides (MICs, approximately 1 µM) were about 10-fold more potent than the intact NPY (MIC, approximately 10 µM). The enhancement was weakened by the replacement of the N terminus by negatively charged residues and/or acylation of the alpha -amino group. These results suggest that only the alpha -helical region of NPY is necessary for the antimicrobial activity and that the net charge of the peptide is important for the activity.

    TEXT
Top
Abstract
Text
References

Neuropeptide Y (NPY) is an amidated peptide of 36 amino acids and is known to regulate physiological functions, such as food intake, learning behavior, vasoconstriction, and neurotransmitter release (10). In addition to these functions, NPY has been recently reported to have activity against Cryptococcus neoformans, Candida albicans, and Arthroderma simii (8). NPY is suggested to belong to a group of antimicrobial peptides such as dermaseptins, cecropins, or magainins (8), which are helical and devoid of cysteine. The antimicrobial mechanism of this group is considered to involve initial electrostatic interactions between the positive charges of the peptides and the negative charges of the cell membrane, following penetration of the peptides into the membrane, and then formation of lipid bilayer-spanning pores which results in osmolysis (1). It is generally thought that a length of approximately 20 residues is necessary to provide an alpha -helix capable of spanning the bilayer. The three-dimensional structure of NPY is considered to consist of an amphipathic alpha -helix (residues 14 to 32) that corresponds to this length, a polyproline helix (residues 1 to 8), a beta -turn (residues 9 to 13), and a flexible tail (residues 33 to 36) (3, 6). In this study, to determine whether the alpha -helical region is responsible for the antimicrobial activity of NPY, we have investigated the effects of truncation at the N terminus on the activity and found that removal of 10 to 12 amino acids from the N terminus caused a significant increase in the activity. Then, to clarify the involvement of electrostatic interactions in the antimicrobial mechanism of NPY, we have synthesized peptides in which net charges were changed by replacement of the N-terminal residues and/or acylation of the alpha -amino groups.

Porcine NPY (YPSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY-NH2) and its analogs were synthesized on an automated solid-phase peptide synthesizer (PSSM-8; Shimadzu, Kyoto, Japan), using Tenta Gel TG-RAM resin and Fmoc (9-fluorenylmethoxycarbonyl) chemistry as previously de-scribed (5). Acetylation and succinylation of the alpha -amino groups of the NPY analogs were performed before cleavage from the resin as previously described (5). C. albicans ATCC 885-653, which was originally from the Institute of Virology and Microbiology of the Ukraine Academy of Sciences, was a generous gift of Elena Ivanova of the Pacific Institution of Bioorganic Chemistry, Vladivostok, Russia. Activity against C. albicans was measured in sterilized 96-well plates (ICN Biomedicals, Aurora, Ohio) according to the method of Mor et al. (4). The concentrations of the synthetic peptide solutions were determined by measuring the optical density at 275 nm due to tyrosine, because the peptides did not include any other aromatic amino acids and the acylation of the alpha -amino groups of the peptides did not affect the absorbance. Different concentrations of peptides were added to suspensions containing 106 spores/ml in Sabouraud dextrose broth. The inhibition of growth was determined by measuring the optical density at 492 nm after incubation for 24 h at 30°C with an MTP-22 microplate photometer (Corona, Ibaraki, Japan). The effect of the peptides on cell viability was determined according to the method of Langner et al. (2).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   MICs of NPY and its analogs for C. albicans

We have synthesized porcine NPY and its truncated analogs, in which 10 to 12 amino acids were eliminated and the N termini were replaced. The MICs of all synthesized peptides are summarized in Table 1. Porcine NPY had a MIC (10 to 12 µM) for C. albicans similar to that reported for human NPY (30 µg/ml, 7 µM) (8). This result was expected due to the fact that porcine NPY differs from human NPY only in a single amino acid residue---position 17 has a leucine in porcine NPY and a methionine in human NPY. All truncated and N-terminally substituted analogs showed enhanced antimicrobial activity. Especially the activities of [Lys13]NPY(13-36), [Asn12]NPY(12-36), and [Lys11]NPY(11-36) were about 10-fold higher than that of the intact NPY. A recent nuclear magnetic resonance study by members of our group revealed that in such truncated analogs of NPY, the alpha -helical region spans almost the entire length of the peptide (7). These results suggest that only the alpha -helical region of NPY is necessary for the antimicrobial activity.

The MICs tended to increase when acidic amino acids were located at the N termini {[Asp13]NPY(13-36), [Asp12]NPY(12-36), [Glu12]NPY(12-36), and [Glu11]NPY(11-36)}, suggesting that the negative charges at the N terminus have a repressive effect on the antimicrobial activity. This explanation is supported by the results of the acylation of the alpha -amino groups in the analogs except for [Lys12]NPY(12-36) (Table 2). Acetylation of [Asn12]NPY(12-36), [Thr12]NPY(12-36), and [Asp12]NPY(12-36) increased the MIC, with a change in the net charge at the N terminus from +1 to 0. Succinylation of these analogs, in which the N-terminal charge was changed to -1, led to more increased MICs.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2.   MICs of the acylated analogs of NPY for C. albicans

In order to determine whether the activity of the peptides is fungistatic or fungicidal, the viable cells were counted after incubation of the strain in the presence of NPY or [Lys13]NPY(13-36), one of the most active analogs, at concentrations which were 5- and 10-fold higher than their MICs. The results shown in Table 3 indicate that the peptides were fungicidal for C. albicans. The kinetic kill assay also indicated that the N-terminal truncation enhanced the antimicrobial activity of NPY.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 3.   Fungicidal effects of NPY and [Lys13]NPY(13-36) on C. albicansa

Thus, we found that the fungicidal activity of porcine NPY for C. albicans was enhanced significantly by N-terminal truncation. The enhancement of the activity in the truncated analogs can be explained, at least partly, by the net charge. The truncated analogs have lost charged amino acids in the N-terminal sequence (Lys4, Asp6, Glu10, and Asp11), and the net charge of the analogs was more positive than that of the intact NPY. Such an increase in the net positive charge of the analogs is expected to cause stronger electrostatic interactions with the target membrane. The increase in negative charges by replacement of the N termini with acidic amino acids or acylation of the alpha -amino groups is considered to weaken this interaction. In the case of cecropin P1 from pig intestine, a free amino terminus was identified to be essential for its high antimicrobial activity (9). Because the truncated analog of NPY with lysine at the N terminus retained high antimicrobial activity after acylation, the varepsilon -amino group of the N-terminal lysine seems to be able to substitute for the alpha -amino group.

    ACKNOWLEDGMENTS

We thank Kazuo Omi (Shionogi Research Laboratories, Shionogi and Co., Ltd.) for helpful comments concerning the kinetic kill assay in which dilution plating techniques were used.

Mayumi Shimizu was an Industrial Technology Researcher in the New Energy and Industrial Technology Development Organization.

    FOOTNOTES

* Corresponding author. Mailing address: Osaka National Research Institute, AIST, 1-8-31 Midorigaoka, Ikeda, Osaka 563-8577, Japan. Phone: 81-727-51-9521. Fax: 81-727-51-9628. E-mail: yumoto{at}onri.go.jp.

    REFERENCES
Top
Abstract
Text
References

1. Blondelle, S. E., and R. A. Houghten. 1992. Design of model amphipathic peptides having potent antimicrobial activities. Biochemistry 31:12688-12694[Medline].
2. Langner, C. A., J. K. Lodge, S. J. Travis, J. E. Caldwell, T. Lu, Q. Li, M. L. Bryant, B. Devadas, G. W. Gokel, G. S. Kobayashi, and J. I. Gordon. 1992. 4-Oxatetradecanoic acid is fungicidal for Cryptococcus neoformans and inhibits replication of human immunodeficiency virus I. J. Biol. Chem. 267:17159-17169[Abstract/Free Full Text].
3. Larhammar, D., C. Söderberg, and A. G. Blomqvist. 1993. Evolution of the neuropeptide Y family of peptides, p. 1-30. In W. F. Colmers, and C. Wahlestedt (ed.), The biology of neuropeptide Y and related peptides. Humana Press, Totowa, N.J.
4. Mor, A., K. Hani, and P. Nicolas. 1994. The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. J. Biol. Chem. 269:31635-31641[Abstract/Free Full Text].
5. Murase, S., N. Yumoto, M. G. Petukhov, and S. Yoshikawa. 1996. Acylation of the alpha -amino group in neuropeptide Y(12-36) increases binding affinity for the Y2 receptor. J. Biochem. 119:37-41[Abstract/Free Full Text].
6. Schwartz, T. W., J. Fuhlendorff, L. L. Kjems, M. S. Kristensen, M. Vervelde, M. O'Hare, J. L. Krstenansky, and B. Bjørnholm. 1990. Signal epitopes in the three-dimensional structure of neuropeptide Y. Ann. N.Y. Acad. Sci. 611:35-47[Medline].
7. Uegaki, K., S. Murase, N. Nemoto, Y. Kobayashi, S. Yoshikawa, and N. Yumoto. 1997. Effects of covalent dimerization on the structure and function of the carboxy-terminal fragment of neuropeptide Y. Biochem. Biophys. Res. Commun. 241:737-743[Medline].
8. Vouldoukis, I., Y. Shai, P. Nicolas, and A. Mor. 1996. Broad spectrum antibiotic activity of skin-PYY. FEBS Lett. 380:237-240[Medline].
9. Vunnam, S., P. Juvvadi, and R. B. Merrifield. 1997. Synthesis and antibacterial action of cecropin and proline-arginine-rich peptides from pig intestine. J. Pept. Res. 49:59-66[Medline].
10. Wahlestedt, C., and D. J. Reis. 1993. Neuropeptide Y-related peptides and their receptors---are the receptors potential therapeutic drug targets? Annu. Rev. Pharmacol. Toxicol. 32:309-352.


Antimicrobial Agents and Chemotherapy, October 1998, p. 2745-2746, Vol. 42, No. 10
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Rotem, S., Radzishevsky, I., Mor, A. (2006). Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives.. Antimicrob. Agents Chemother. 50: 2666-2672 [Abstract] [Full Text]  
  • Nordahl, E. A., Rydengard, V., Morgelin, M., Schmidtchen, A. (2005). Domain 5 of High Molecular Weight Kininogen Is Antibacterial. J. Biol. Chem. 280: 34832-34839 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, M.
Right arrow Articles by Yumoto, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, M.
Right arrow Articles by Yumoto, N.